BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24565424)

  • 1. Pertussis: a persistent cause of morbidity and mortality in young infants.
    Cantey JB; Sánchez PJ; Tran J; Chung W; Siegel JD
    J Pediatr; 2014 Jun; 164(6):1489-92.e1. PubMed ID: 24565424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
    Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
    Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection.
    Healy CM; Rench MA; Wootton SH; Castagnini LA
    Pediatr Infect Dis J; 2015 Jan; 34(1):22-6. PubMed ID: 24992123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of cocooning against pertussis in a high-risk population.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2011 Jan; 52(2):157-62. PubMed ID: 21288837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.
    Castagnini LA; Healy CM; Rench MA; Wootton SH; Munoz FM; Baker CJ
    Clin Infect Dis; 2012 Jan; 54(1):78-84. PubMed ID: 22075790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy.
    Fortner KB; Kuller JA; Rhee EJ; Edwards KM
    Obstet Gynecol Surv; 2012 Apr; 67(4):251-7. PubMed ID: 22495061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whooping cough in adults: an update on a reemerging infection.
    Paisley RD; Blaylock J; Hartzell JD
    Am J Med; 2012 Feb; 125(2):141-3. PubMed ID: 22269615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. California pertussis epidemic, 2010.
    Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
    J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent pertussis.
    Ortolon K
    Tex Med; 2002 Jun; 98(6):38-42. PubMed ID: 12073900
    [No Abstract]   [Full Text] [Related]  

  • 15. Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths.
    Kuehn BM
    JAMA; 2010 Dec; 304(24):2684-6. PubMed ID: 21177500
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal immunization to benefit the mother, fetus, and infant.
    Swamy GK; Garcia-Putnam R
    Obstet Gynecol Clin North Am; 2014 Dec; 41(4):521-34. PubMed ID: 25454988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of pertussis in infants: time has finally come?
    Safadi MA
    Expert Rev Vaccines; 2015 Jun; 14(6):781-3. PubMed ID: 25968349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-acquired pertussis among newborns--Texas, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(22):600-3. PubMed ID: 18528316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
    Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
    Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.